b12 semaglutide with The Dynamic Duo for Slimming

Recently, the US Food and Drug Administration (FDA) approved semaglutide for patients with obesity or those who are overweight [14]

In December 2025, the FDA approved the first oral GLP-1 pill for weight management, and compounding pharmacies have introduced oral disintegrating tablet (ODT) formulations that bypass the digestive system entirely

You'll complete a quick online quiz, undergo a clinician review, and - if approved - receive your medication via overnight delivery

Cell Rep 2019;28:257-266

If youre trying to keep protein high and calories low while on semaglutide, be sure to keep an eye on your intake of added sugars and refined carbs, especially sources that are low in fiber, making them easy to overeat

GLP-1 medications have demonstrated effects beyond weight loss that are directly relevant to Medicare's covered disease populations: reductions in cardiovascular events in patients with established heart disease (Wegovy's FDA approval for cardiovascular risk reduction), improvements in blood sugar control, reductions in sleep apnea severity, and improvements in kidney function